Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined array key "thumbnail" in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 25
StackHealth / SBRT extends progression‑free survival in oligometastatic breast cancer

OLIGOMA Trial: SBRT Extends PFS in Oligometastatic Breast Cancer

oncodaily - The OLIGOMA trial presented at ESTRO 2026 brings new attention to one of the most debated questions in metastatic breast cancer: can treating limited metastatic sites with stereotactic body radiotherapy […]

AI Summary: A randomized trial shows stereotactic body radiotherapy (SBRT) targeting limited metastatic breast lesions prolongs progression‑free survival, offering longer disease control for selected patients with oligometastatic disease. Toxicity was manageable, suggesting SBRT could become a pragmatic, tissue‑sparing option to delay systemic therapy escalation.

#oncology #cancerresearch #clinicaltrials

ESTRO reaction: clinicians and advocates amplify SBRT findings

9 days / oncodaily

13 days / oncodaily

13 days / oncodaily


EXTEND and practice: metastasis-directed therapy, guidelines, and AI

9 days / esmo

9 days / nature

12 days / oncodaily

13 days / oncodaily


OLIGOMA: SBRT extends PFS in oligometastatic breast cancer

13 days / oncodaily

14 days / oncodaily

14 days / medicalxpress


All Other Stories

2 days / esmo

2 days / oncodaily

5 days / oncodaily

6 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

8 days / oncodaily

13 days / medicalxpress


Back to Top / Monday, May 18, 2026, 12:21 am / permalink 23933 / 23 stories in 13 days /


Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61


Related Stories



Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

High‑dose targeted radiation shows promise for huge bile duct tumors / 1 month

Two high‑dose radiotherapy sessions safely treat localized prostate cancer / 11 days

ESMO issues new metastatic colorectal cancer clinical guideline / 6 wks

Teclistamab outperforms standard regimens in earlier-line relapsed myeloma / 46 hrs

Common asthma drug may overcome immunotherapy resistance in cancers / 11 days

Retifanlimab plus chemotherapy extends survival in advanced squamous anal cancer / 13 days

Zoldonrasib shows durable responses in KRAS G12D lung cancer / 5 wks

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Drug Development, Telemedicine, Behavioral Health, Medical Devices and look for the RSS link.



NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.